R. Altman, K. Brandt, M. Hochberg, R. Moskowitz, N. Bellamy et al., Design and conduct of clinical trials in patients with osteoarthritis: Recommendations from a task force of the Osteoarthritis Research Society, Osteoarthritis and Cartilage, vol.4, issue.4, pp.217-260, 1996.
DOI : 10.1016/S1063-4584(05)80101-3

N. Bellamy, J. Kirwan, M. Boers, P. Brooks, V. Strand et al., Recommendations for a core set of outcome measures for future phase III clinical trials in knee, hip, and hand osteoarthritis. Consensus development at OMERACT III, J Rheumatol, vol.24, issue.4, pp.799-802, 1997.

J. Wright, Interpreting Health-Related Quality of Life Scores, Medical Care, vol.41, issue.5, pp.597-605, 2003.
DOI : 10.1097/00005650-200305000-00006

D. Beaton, M. Boers, and G. Wells, Many faces of the minimal clinically important difference

R. Crosby, R. Kolotkin, and G. Williams, Defining clinically meaningful change in health-related quality of life, Journal of Clinical Epidemiology, vol.56, issue.5, pp.395-407, 2003.
DOI : 10.1016/S0895-4356(03)00044-1

F. Tubach, P. Ravaud, G. Baron, B. Falissard, I. Logeart et al., Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement, Annals of the Rheumatic Diseases, vol.64, issue.1, pp.29-33, 2005.
DOI : 10.1136/ard.2004.022905

D. Cella, E. Hahn, and K. Dineen, Meaningful change in cancer-specific quality of life scores: differences between improvement and worsening, Quality of Life Research, vol.11, issue.3, pp.207-228, 2002.
DOI : 10.1023/A:1015276414526

G. Guyatt and R. Jaeschke, Reassessing Quality-of-Life Instruments in the Evaluation of New Drugs, PharmacoEconomics, vol.12, issue.6
DOI : 10.2165/00019053-199712060-00002

A. Schwartz, P. Meek, L. Nail, J. Fargo, M. Lundquist et al., Measurement of fatigue: Determining minimally important clinical differences, Clinical Therapeutics, vol.24, issue.3, pp.239-283, 2002.
DOI : 10.1016/S0149-2918(02)85097-4

R. Jaeschke, J. Singer, and G. Guyatt, Measurement of health status, Controlled Clinical Trials, vol.10, issue.4, pp.407-422, 1989.
DOI : 10.1016/0197-2456(89)90005-6

E. Juniper, G. Guyatt, A. Willan, and L. Griffith, Determining a minimal important change in a disease-specific quality of life questionnaire, Journal of Clinical Epidemiology, vol.47, issue.1, pp.81-88, 1994.
DOI : 10.1016/0895-4356(94)90036-1

F. Tubach, P. Ravaud, G. Baron, B. Falissard, I. Logeart et al., Evaluation of clinically relevant states in patient reported outcomes in knee and hip osteoarthritis: the patient acceptable symptom state, Annals of the Rheumatic Diseases, vol.64, issue.1, pp.34-41, 2005.
DOI : 10.1136/ard.2004.023028

F. Tubach, M. Dougados, B. Falissard, G. Baron, I. Logeart et al., Feeling good rather than feeling better matters more to patients, Arthritis & Rheumatism, vol.5, issue.4, pp.526-556, 2006.
DOI : 10.1002/art.22110

J. Cohen, The Cost of Dichotomization, Applied Psychological Measurement, vol.7, issue.3, pp.249-53, 1983.
DOI : 10.1177/014662168300700301

D. Altman and P. Royston, The cost of dichotomising continuous variables, BMJ, vol.332, issue.7549, p.1080, 2006.
DOI : 10.1136/bmj.332.7549.1080

J. Brozek, G. Guyatt, and H. Schunemann, How a well-grounded minimal important difference can enhance transparency of labelling claims and improve interpretation of a patient reported outcome measure

R. Dworkin, D. Turk, J. Farrar, J. Haythornthwaite, M. Jensen et al., Core outcome measures for chronic pain clinical trials: IMMPACT recommendations, Pain, vol.113, issue.1, pp.69-189, 2005.
DOI : 10.1016/j.pain.2004.09.012

F. Tubach, P. Ravaud, D. Beaton, M. Boers, C. Bombardier et al., Minimal clinically important improvement and patient acceptable symptom state for subjective outcome measures in rheumatic disorders, J Rheumatol, vol.34, issue.5, pp.1188-93, 2007.
URL : https://hal.archives-ouvertes.fr/inserm-00155664

F. Tubach, G. Wells, P. Ravaud, and M. Dougados, Minimal clinically important difference, low disease activity state, and patient acceptable symptom state: methodological issues, J Rheumatol, vol.32, issue.10, pp.2025-2034, 2005.

M. Kvamme, I. Kristiansen, E. Lie, and T. Kvien, Identification of Cutpoints for Acceptable Health Status and Important Improvement in Patient-Reported Outcomes, in Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis, The Journal of Rheumatology, vol.37, issue.1, pp.26-31, 2009.
DOI : 10.3899/jrheum.090449

F. Tubach, T. Pham, J. Skomsvoll, K. Mikkelsen, O. Bjorneboe et al., Stability of the patient acceptable symptomatic state over time in outcome criteria in ankylosing spondylitis, Arthritis & Rheumatism, vol.30, issue.6, pp.960-963, 2006.
DOI : 10.1002/art.22342

T. Klooster, P. Drossaers-bakker, K. Taal, E. Van-de-laar, and M. , Patient-perceived satisfactory improvement (PPSI): Interpreting meaningful change in pain from the patient???s perspective, Pain, vol.121, issue.1, pp.151-158, 2006.
DOI : 10.1016/j.pain.2005.12.021

M. Dougados, M. Luo, W. Maksymowych, J. Chmiel, N. Chen et al., Evaluation of the patient acceptable symptom state as an outcome measure in patients with ankylosing spondylitis: Data from a randomized controlled trial, Arthritis & Rheumatism, vol.52, issue.4, pp.553-60, 2008.
DOI : 10.1002/art.23527

W. Maksymowych, K. Gooch, M. Dougados, R. Wong, N. Chen et al., Thresholds of patient-reported outcomes that define the patient acceptable symptom state in ankylosing spondylitis vary over time and by treatment and patient characteristics, Arthritis Care & Research, vol.60, issue.Suppl, pp.826-860, 2010.
DOI : 10.1002/acr.20131

W. Maksymowych, R. Richardson, C. Mallon, D. Van-der-heijde, and A. Boonen, Evaluation and validation of the patient acceptable symptom state (PASS) in patients with ankylosing spondylitis, Arthritis & Rheumatism, vol.62, issue.1, pp.133-142, 2007.
DOI : 10.1002/art.22469

F. Arnett, S. Edworthy, D. Bloch, D. Mcshane, J. Fries et al., The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis 28. van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria, Arthritis Rheum. Arthritis Rheum, vol.3127, issue.34, pp.315-24361, 1984.

R. Altman, G. Alarcon, D. Appelrouth, D. Bloch, D. Borenstein et al., The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hand, Arthritis & Rheumatism, vol.62, issue.11, pp.1601-1611, 1990.
DOI : 10.1002/art.1780331101

R. Altman, G. Alarcon, D. Appelrouth, D. Bloch, D. Borenstein et al., The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip, Arthritis & Rheumatism, vol.29, issue.5, pp.505-519, 1991.
DOI : 10.1002/art.1780340502

R. Altman, E. Asch, D. Bloch, G. Bole, D. Borenstein et al., Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association Measurement of patient outcome in arthritis, Arthritis Rheum. Arthritis Rheum, vol.2923, issue.322, pp.1039-49137, 1980.

S. Garrett, T. Jenkinson, L. Kennedy, H. Whitelock, P. Gaisford et al., A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index, J Rheumatol, vol.21, issue.12, pp.2286-91, 1994.

A. Calin, S. Garrett, H. Whitelock, L. Kennedy, O. Hea et al., A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index, J Rheumatol, vol.21, issue.12, pp.2281-2286, 1994.

D. A. Kelli, M. J. Joanne, B. R. Jordan, and B. Virginia, Validity, factor structure, and clinical relevance of the AUSCAN osteoarthritis hand index, Arthritis Rheum, vol.54, issue.2, pp.551-557, 2006.

N. Bellamy, W. Buchanan, C. Goldsmith, J. Campbell, and L. Stitt, Validation of WOMAC: A health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthitis of the hip or knee, J Rheumatol, vol.15, pp.1833-1873, 1995.

M. Roland and R. Morris, A Study of the Natural History of Back Pain, Spine, vol.8, issue.2, pp.141-145, 1983.
DOI : 10.1097/00007632-198303000-00004

G. Wells, J. Anderson, D. Beaton, N. Bellamy, M. Boers et al., Minimal clinically important difference module: summary, recommendations, and research agenda, J Rheumatol, vol.28, issue.2, pp.452-456, 2001.

F. Tubach, B. Giraudeau, P. Ravaud, M. Sprangers, E. De-regt et al., 1110-1. 40 The variability in MCII and PASS estimates did not have an impact on treatment effect estimates Which chronic conditions are associated with better or poorer quality of life? Comparison of transformed visual analogue and native numerical rating scaled patient responses to the WOMAC Index, Disease Activity State in Rheumatoid Arthritis)):23. 43. Wells G al. MCID/Low Disease Activity State Workshop: Summary, Recommendations, and Research Agenda, pp.725-8895, 2000.